header-logo header-logo

23 September 2016
Issue: 7715 / Categories: Case law , Law digest , In Court
printer mail-detail

EU

Sun Pharmaceuticals Industries Ltd and another company v European Commission T-460/13, [2016] All ER (D) 52 (Sep)

The General Court of the European Union dismissed the application by Sun Pharmaceuticals Industries Ltd (formerly Ranbaxy Laboratories Ltd) and Ranbaxy (UK) Ltd for annulment in part of Commission Decision C(2013) 3803 final of 19 June 2013 relating to a proceeding under Art 101 of the Treaty on the Functioning of the European Union and Art 53 of the European Economic Area Agreement and for reduction of the amount of the fine imposed on those companies by that decision. The General Court held that none of the pleas in law relied on by them in support of their application was well founded.

If you are not a subscriber, subscribe now to read this content
If you are already a subscriber sign in
...or Register for two weeks' free access to subscriber content

MOVERS & SHAKERS

Clyde & Co—Nav Juty

Clyde & Co—Nav Juty

ArcelorMittal global head of disputes Nav Juty appointed as partner

Shakespeare Martineau—Caroline Hastings

Shakespeare Martineau—Caroline Hastings

Shakespeare Martineau strengthens Birmingham agricultural team

Fieldfisher—Peter McKeever

Fieldfisher—Peter McKeever

Fieldfisher Ireland appoints Peter McKeever as real estate partner

NEWS
The Solicitors Regulation Authority (SRA) has hiked the practising fee for individuals from £190 to £240, as the regulator implements a ‘reset’
Businesses incorporating open-source software into commercial products could face obligations to disclose valuable source code, with AI-assisted development making licensing risks harder to track
Careless client checks do not automatically make a solicitor dishonest, but deliberately avoiding confirmation of suspected wrongdoing can cross the line
Construction workers injured in comparable accidents can face sharply different routes to compensation on opposite sides of the Atlantic
Victims of undue influence may have more options than simply unwinding a tainted transaction, with courts able to order profits accounts, compensation and, exceptionally, severance
back-to-top-scroll